Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,522 | 425 | 99.7% |
| Education | $22.12 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,995 | 194 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $591.34 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $485.05 | 27 | $0 (2024) |
| Celgene Corporation | $426.05 | 42 | $0 (2024) |
| Janssen Biotech, Inc. | $344.90 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $226.68 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $174.02 | 10 | $0 (2024) |
| QOL Medical, LLC | $156.21 | 8 | $0 (2024) |
| Ardelyx, Inc. | $148.10 | 8 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $120.72 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,895 | 107 | ABBVIE INC. ($988.81) |
| 2023 | $1,619 | 97 | ABBVIE INC. ($583.07) |
| 2022 | $2,025 | 119 | ABBVIE INC. ($1,173) |
| 2021 | $2,005 | 103 | AbbVie Inc. ($1,250) |
All Payment Transactions
426 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.39 | General |
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/02/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: GI | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: VIROLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 472 | 585 | $175,236 | $37,152 |
| 2022 | 5 | 491 | 550 | $166,274 | $35,584 |
| 2021 | 6 | 442 | 513 | $154,645 | $37,925 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 202 | $68,575 | $14,901 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 259 | $61,725 | $12,558 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $32,517 | $6,912 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $9,910 | $2,180 | 22.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $2,509 | $600.10 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 204 | 259 | $61,725 | $13,345 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 125 | 125 | $55,680 | $11,836 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 97 | $32,930 | $7,304 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $11,659 | $2,340 | 20.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 29 | $4,280 | $759.63 | 17.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 120 | 120 | $53,453 | $12,277 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 136 | $42,329 | $10,835 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 135 | 186 | $42,672 | $10,400 | 24.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $9,583 | $2,369 | 24.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 17 | 17 | $3,544 | $1,325 | 37.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 21 | $3,065 | $718.60 | 23.4% |
About Ashley Bouknight
Ashley Bouknight is a Family healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2020. The National Provider Identifier (NPI) number assigned to this provider is 1205440351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Bouknight has received a total of $7,544 in payments from pharmaceutical and medical device companies, with $1,895 received in 2024. These payments were reported across 426 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,522).
As a Medicare-enrolled provider, Bouknight has provided services to 1,405 Medicare beneficiaries, totaling 1,648 services with total Medicare billing of $110,660. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Oklahoma City, OK
- Active Since 09/06/2020
- Last Updated 09/06/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1205440351
Products in Payments
- HUMIRA (Biological) $1,155
- RINVOQ (Biological) $915.89
- CREON (Drug) $700.82
- SKYRIZI (Biological) $683.91
- ZEPOSIA (Drug) $504.09
- XIFAXAN (Drug) $432.36
- STELARA (Biological) $429.85
- LINZESS (Drug) $276.54
- ENTYVIO (Biological) $244.20
- DIFICID (Drug) $226.68
- GATTEX (Drug) $226.68
- DUPIXENT (Biological) $219.26
- TRULANCE (Drug) $158.98
- ZENPEP (Drug) $155.48
- IBSRELA (Drug) $148.10
- MAVYRET (Drug) $104.71
- VIBERZI (Drug) $87.47
- SUCRAID (Drug) $85.93
- INJECTAFER (Drug) $73.28
- Sucraid (Drug) $70.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Oklahoma City
Mrs. Julia John Samuel, Dnp, Fnp-C, DNP, FNP-C
Family — Payments: $12,946
Kristina Snyder, Np, NP
Family — Payments: $11,953
Lindi Ciglar, Aprn, APRN
Family — Payments: $11,092
Anne Dude, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $10,000
Mrs. Xiomara Porras, Rn, RN
Family — Payments: $9,028
Mrs. Michelle Stapp, Cnp, CNP
Family — Payments: $7,931